Onconova Therapeutics
ONTX
#9569
Rank
$20.9 M
Marketcap
$1.00
Share price
-0.47%
Change (1 day)
-10.33%
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2024 (TTM): $0.22 Million USD

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.22 Million USD. In 2023 the company made a revenue of $0.22 Million USD a decrease over the revenue in the year 2022 that were of $0.22 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.22 M0%
2023 $0.22 M0%
2022 $0.22 M0%
2021 $0.22 M-2.16%
2020 $0.23 M-89.42%
2019 $2.18 M77.77%
2018 $1.22 M56.04%
2017 $0.78 M-85.81%
2016 $5.54 M-51.59%
2015 $11.45 M1332%
2014 $0.8 M-83.17%
2013 $4.75 M-89.71%
2012 $46.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$25.72 M 11,284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.10 B 487,166.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.99 B 6,635,740.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$75.76 M 33,426.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.63 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA